PBE vs. HRTS ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Tema Cardiovascular and Metabolic ETF (HRTS)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$69.56
Average Daily Volume
6,596
30
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.Grade (RS Rating)
Last Trade
$31.33
Average Daily Volume
14,168
36
Performance
| Period | PBE | HRTS |
|---|---|---|
| 30 Days | 2.96% | -6.41% |
| 60 Days | -0.81% | -7.91% |
| 90 Days | -2.51% | -10.69% |
| 12 Months | 22.72% | 17.61% |
PBE Overweight 27 Positions Relative to HRTS
| Symbol | Grade | Weight | |
|---|---|---|---|
| UTHR | C | 5.74% | |
| ILMN | D | 5.64% | |
| BIIB | F | 4.21% | |
| NBIX | C | 4.18% | |
| XNCR | B | 3.88% | |
| EXEL | B | 3.86% | |
| TGTX | B | 3.78% | |
| BMRN | D | 3.76% | |
| MNKD | C | 3.7% | |
| NTRA | B | 3.56% | |
| INCY | C | 3.35% | |
| VCYT | B | 3.28% | |
| ACAD | D | 3.06% | |
| CPRX | C | 3.0% | |
| BPMC | C | 2.91% | |
| TECH | D | 2.89% | |
| VCEL | B | 2.79% | |
| OPK | C | 2.78% | |
| RGEN | D | 2.76% | |
| PTGX | C | 2.75% | |
| QGEN | D | 2.59% | |
| BCRX | D | 2.56% | |
| HALO | F | 2.42% | |
| COLL | F | 2.27% | |
| CDNA | D | 1.92% | |
| NVAX | F | 1.83% | |
| MYGN | F | 1.61% |
PBE Underweight 33 Positions Relative to HRTS
| Symbol | Grade | Weight | |
|---|---|---|---|
| LLY | F | -6.44% | |
| VRTX | F | -5.64% | |
| CRNX | C | -4.0% | |
| BBIO | F | -3.69% | |
| CYTK | F | -3.47% | |
| BSX | B | -2.99% | |
| ASND | D | -2.88% | |
| MDT | D | -2.79% | |
| MIRM | B | -2.6% | |
| DXCM | D | -2.57% | |
| MREO | F | -2.49% | |
| IONS | F | -2.42% | |
| MASI | A | -2.39% | |
| KROS | D | -2.1% | |
| EW | C | -1.91% | |
| MLYS | F | -1.89% | |
| PODD | C | -1.88% | |
| RCKT | F | -1.8% | |
| ARWR | F | -1.76% | |
| RARE | D | -1.71% | |
| NTLA | F | -1.66% | |
| MDGL | B | -1.46% | |
| WST | C | -1.43% | |
| AKRO | B | -1.28% | |
| NVS | D | -1.26% | |
| VKTX | F | -1.14% | |
| NARI | C | -0.97% | |
| EWTX | C | -0.96% | |
| SLN | F | -0.91% | |
| TERN | F | -0.7% | |
| VERV | F | -0.64% | |
| TNYA | C | -0.43% | |
| RANI | F | -0.31% |
PBE: Top Represented Industries & Keywords
HRTS: Top Represented Industries & Keywords
Compare ETFs
